Expanding Medicaid is associated with an increase in receipt of guideline-concordant treatment among nonelderly women newly ...
A case-control study of over 2,000 women found that 38% of postmenopausal, hormone receptor-positive breast cancer cases can ...
The efficacy seen in a small study, especially in GNAS-mutated tumors, could influence care, but the rarity of the cancer is ...
The odds of having two types of cancer at the same time is rare, especially two types of breast cancer. The dual diagnosis ...
Hormone therapy (also called hormonal therapy or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering with the ...
At her job at the Breast Cancer Research Foundation, Sadia Zapp talks about the disease all day, every day. But her best advice is purely personal.
New research published online-ahead-of-print in Journal of the National Comprehensive Cancer Network found that people with ...
The biggest increase in 2-year survival associated with Medicaid expansion was among patients with stage III disease, with a ...
The study provides insights into the development of birds, revealing an interplay of hormone-dependent and ...
A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback